Showing results (41-50 of 291) with videos related to

Sort By:
Pageof 30
Clinical & Translational Immunology|May 20, 2016
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsLeandro J Carreño, Noemí A Saavedra-Ávila, Steven A Porcelli
Mbio|January 20, 2021
Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosisCatherine Vilchèze, Steven A Porcelli, John Chan, et al.
Journal of Clinical Immunology|August 15, 2000
Antigen-specific regulation of CD1 expression in humansM Ulanova, A Tarkowski, S A Porcelli, et al.
Journal of Immunological Methods|January 22, 2013
In vitro derivation of macrophage from guinea pig bone marrow with human M-CSFKarl O A Yu, Steven A Porcelli, Howard A Shuman
Minerva Ginecologica|January 1, 1997
[Lipoprotein(a) and the cardiovascular risk during estrogen-progestin replacement therapy in postmenopause]A Porcelli, L Calleri, D Gallello, et al.
The Journal of Experimental Medicine|February 16, 2005
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector moleculeVivek Rao, Nagatoshi Fujiwara, Steven A Porcelli, et al.
Molecular Microbiology|July 2, 2004
Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune responseVolker Briken, Steven A Porcelli, Gurdyal S Besra, et al.
Minerva Ginecologica|January 1, 1997
[Bacterial vaginosis and premature membrane rupture: an open study. Preliminary data]L Calleri, A Porcelli, D Gallello, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1989
Maternal and embryonal/fetal beta-endorphin concentrations during the first trimester of pregnancyN Surico, A Lanzani, T Crivello, et al.
Pageof 30